Lipella Pharmaceuticals Inc. (LIPO)

Import this data to Google Sheets with:

=jivedata("LIPO","financials")

Full statements spill as a table. For one cell: =jivedata("LIPO","Revenue") or =jivedata("LIPO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Lipella Pharmaceuticals Inc.

LIPO • CIK 0001347242

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Revenues	$184.156	$449.617	$536.357	$389.783
Research and Development Expense	$2,547.677	$3,038.836	$3,613.187	$3,568.365
General and Administrative Expense	$226.192	$2,156.734	$2,003.712	$2,231.378
Operating Costs and Expenses	$2,773.869	$5,195.57	$5,616.899	$5,799.743
Operating Income (Loss)	$-2,589.713	$-4,745.953	$-5,080.542	$-5,409.96
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-2,597.692	$-4,618.965	$-5,016.264	$-5,329.759
Weighted Average Number of Shares Outstanding, Basic	4,060,624	6,003,074	1,048,185	3,700,118
Investment Income, Interest	$1.678	$137.836	$64.278	$80.201
Interest Expense	$9.612	$10.848	$10.848	$10.848
Nonoperating Income (Expense)	$-7.979	$126.988	$64.278	$80.201

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Cash and Cash Equivalents, at Carrying Value	$5,121.743	$3,293.738	$2,184.863	$1,855.771
Accounts Receivable, after Allowance for Credit Loss, Current	$113.655	$32.286	$84.713	$84.713
Prepaid Expense, Current	$563.891	$103.256	$347.676	$223.517
Assets, Current	$5,799.289	$3,429.28	$2,617.252	$2,079.288
Furniture and Fixtures, Gross	—	$140.294	$140.294	$140.294
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	—	$127.544	$130.43	$132.595
Property, Plant and Equipment, Net	—	$12.75	$9.864	$7.699
Operating Lease, Right-of-Use Asset	$150.821	$135.144	$46.754	$262.823
Assets	$5,950.11	$3,577.174	$2,673.87	$2,349.81
Accounts Payable, Current	$384.357	$138.016	$388.191	$462.892
Accrued Liabilities, Current	$389.209	$77.28	$237.886	$34.938
Operating Lease, Liability, Current	$58.262	$89.223	$47.605	$44.267
Liabilities, Current	$1,178.256	$385.355	$754.417	$642.399
Operating Lease, Liability, Noncurrent	$96.258	$47.371	$47.371	$219.816
Liabilities	$1,274.514	$432.726	$754.417	$862.215
Preferred Stock, Value, Issued	$0.159	—	$0.033	$0.033
Common Stock, Value, Issued	$0.574	$0.605	$0.121	$0.462
Additional Paid in Capital	$10,379.9	$13,467.686	$17,259.406	$20,715.326
Retained Earnings (Accumulated Deficit)	$-5,704.878	$-10,323.843	$-15,340.107	$-19,228.194
Stockholders' Equity Attributable to Parent	$4,675.596	$3,144.448	$1,919.453	$1,487.595
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	5,743,945	6,053,956	1,208,919	4,620,837

(in thousands, except per share data)	FY 2022	FY 2023	FY 2024	TTM
Net Income (Loss) Attributable to Parent	$-2,597.692	$-4,618.965	$-5,016.264	$-5,329.759
Net Cash Provided by (Used in) Operating Activities	$-1,831.161	$-3,150.172	$-3,950.747	$-4,775.734
Depreciation, Depletion and Amortization	—	$1.685	$2.886	$2.886
Issuance of Stock and Warrants for Services or Claims	—	$121.2	$200	$200
Noncash Contribution Expense	$747.396	$1,355.016	$749.396	$749.396
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$5,121.743	$3,293.738	$2,184.863	$4,304.576
Payments to Acquire Property, Plant, and Equipment	—	$14.434	$14.434	$14.434
Net Cash Provided by (Used in) Investing Activities	$300.546	$-14.434	$-14.434	$-14.434
Repayments of Notes Payable	—	$25	$25	$25
Net Cash Provided by (Used in) Financing Activities	$5,238.53	$1,336.601	$2,841.872	$5,277.768
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$3,707.915	$-1,828.005	$-1,108.875	$502.035
Increase (Decrease) in Prepaid Expense	$470.175	$-460.634	$244.42	$-471.635
Increase (Decrease) in Accounts Payable	$337.456	$-246.341	$250.175	$3.439
Increase (Decrease) in Accrued Liabilities	$237.688	$-315.525	$160.606	$-54.835
Increase (Decrease) in Deferred Liabilities	$17.671	$13.004	$-0.1	$19.17
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	—	$11.908	$11.263
Income Taxes Paid, Net	—	$-11.358	—	$-11.358
Proceeds from Stock Options Exercised	—	$121.2	—	$121.2

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("LIPO","financials")

Full statements spill as a table. For one cell: =jivedata("LIPO","Revenue") or =jivedata("LIPO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.